Stratifying the risk of NSAID-related upper gastrointestinal clinical events: Results of a double-blind outcomes study in patients with rheumatoid arthritis-Reference-Cited by-同舟云学术

Stratifying the risk of NSAID-related upper gastrointestinal clinical events: Results of a double-blind outcomes study in patients with rheumatoid arthritis

Published:2002-10 Issue:4 Volume:123 Page:1006-1012
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Laine Loren,Bombardier Claire,Hawkey Christopher J.,Davis Barry,Shapiro Deborah,Brett Christopher,Reicin Alise

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference23 articles.

1. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs;Garcia Rodriguez;Lancet,1994

2. Non-steroidal anti-inflammatory drugs and complications: a risk factor analysis for clinical decision-making;Hansen;Scand J Gastroenterol,1996

3. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis;Bombardier;N Engl J Med,2000

4. Use of many covariates in clinical trials;Tukey;Int Stat Rev,1991

5. Analysis of long term adverse experience data using the weibull model;Shapiro;Drug Info J,1994

Cited by 220 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update S2k-Guideline Helicobacter pylori and gastroduodenal ulcer disease of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS);Zeitschrift für Gastroenterologie;2024-02

2. Graph regularized non-negative matrix factorization with $$L_{2,1}$$ norm regularization terms for drug–target interactions prediction;BMC Bioinformatics;2023-10-03

3. Aktualisierte S2k-Leitlinie Helicobacter pylori und gastroduodenale Ulkuskrankheit der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – Juli 2022 – AWMF-Registernummer: 021–001;Zeitschrift für Gastroenterologie;2023-05

4. Analysis of deprescription strategies of proton pump inhibitors in primary care: a narrative review;Primary Health Care Research & Development;2023

5. Predictors for inappropriate proton pump inhibitor use: observational study in primary care;British Journal of General Practice;2022-06-24